Pharmacogenomics of hypertension treatment

J Rysz, B Franczyk, M Rysz-Górzyńska… - International journal of …, 2020 - mdpi.com
Hypertension is one of the strongest modifiable cardiovascular risk factors, affecting an
increasing number of people worldwide. Apart from poor medication adherence, the low …

Pharmacogenomics and hypertension: current insights

GH Oliveira-Paula, SC Pereira… - Pharmacogenomics …, 2019 - Taylor & Francis
Hypertension is a multifactorial disease that affects approximately one billion subjects
worldwide and is a major risk factor associated with cardiovascular events, including …

Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates

M Saiz-Rodríguez, S Almenara, M Navares-Gómez… - Biomedicines, 2020 - mdpi.com
Several cytochrome P450 (CYP) CYP3A polymorphisms were associated with reduced
enzyme function. We aimed to evaluate the influence of these alleles on the …

Management of hypertension in the elderly and frail patient

L Guasti, M Ambrosetti, M Ferrari, F Marino, M Ferrini… - Drugs & Aging, 2022 - Springer
Hypertension is a frequent finding in elderly patients. Hypertension in older age can be both
associated with frailty and represent a risk factor for frailty. Hypertension is recognized as a …

Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation

Y Zhu, F Wang, Q Li, M Zhu, A Du, W Tang… - Drug Metabolism and …, 2014 - ASPET
Amlodipine is a commonly prescribed calcium channel blocker for the treatment of
hypertension and ischemic heart disease. The drug is slowly cleared in humans primarily via …

Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin

JE Park, KB Kim, SK Bae, BS Moon, KH Liu, JG Shin - Xenobiotica, 2008 - Taylor & Francis
Atorvastatin is a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that
is mainly metabolized by cytochrome P450 (CYP) 3A4. A recent study showed that the lipid …

Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady‐state in Korean epileptic patients

PW Park, YH Seo, JY Ahn, KA Kim… - Journal of clinical …, 2009 - Wiley Online Library
Abstract Background and Objective: Carbamazepine (CBZ) is metabolized mainly by the
CYP3A family of enzymes, which includes CYP3A4 and CYP3A5. Several studies have …

Effect of the P450 oxidoreductase* 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers

JJ Zhang, H Zhang, XL Ding, S Ma, LY Miao - European journal of clinical …, 2013 - Springer
Purpose To assess the influence of the P450 oxidoreductase* 28 SNP (POR* 28) on
tacrolimus pharmacokinetics in the Chinese population. Methods Seventy-one healthy …

CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease

V Bhatnagar, EP Garcia, DT O'Connor… - American journal of …, 2010 - karger.com
Purpose: To explore the association between CYP3A4 and CYP3A5 gene polymorphisms
and blood pressure response to amlodipine among participants from the African-American …

[HTML][HTML] On the two largest Q-eigenvalues of graphs

JF Wang, F Belardo, QX Huang, B Borovićanin - Discrete Mathematics, 2010 - Elsevier
In this paper, we first give an upper bound for the largest signless Laplacian eigenvalue of a
graph and find all the extremal graphs. Secondly, we consider the second-largest signless …